Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China · Delayed Price · Currency is CNY 21.61
+0.38 (1.79%)
Feb 6, 2026, 3:00 PM CST
SHA:605033 Revenue
Shaanxi Meibang Pharmaceutical Group had revenue of 123.56M CNY in the quarter ending September 30, 2025, with 9.17% growth. This brings the company's revenue in the last twelve months to 871.63M, up 13.47% year-over-year. In the year 2024, Shaanxi Meibang Pharmaceutical Group had annual revenue of 885.53M with 26.68% growth.
Revenue (ttm)
871.63M
Revenue Growth
+13.47%
P/S Ratio
3.29
Revenue / Employee
873.38K
Employees
998
Market Cap
2.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 885.53M | 186.50M | 26.68% |
| Dec 31, 2023 | 699.03M | -207.02M | -22.85% |
| Dec 31, 2022 | 906.05M | 63.56M | 7.54% |
| Dec 31, 2021 | 842.49M | 273.97M | 48.19% |
| Dec 31, 2020 | 568.52M | 52.81M | 10.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition